Neuroscientific Biopharmaceuticals Ltd (NSB) - Total Liabilities

Latest as of December 2025: AU$207.87K AUD ≈ $147.08K USD

Based on the latest financial reports, Neuroscientific Biopharmaceuticals Ltd (NSB) has total liabilities worth AU$207.87K AUD (≈ $147.08K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check NSB cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Neuroscientific Biopharmaceuticals Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Neuroscientific Biopharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Neuroscientific Biopharmaceuticals Ltd.

Neuroscientific Biopharmaceuticals Ltd Competitors by Total Liabilities

The table below lists competitors of Neuroscientific Biopharmaceuticals Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Phapros Tbk PT JK:PEHA	Indonesia	Rp1.01 Trillion
HWH International Inc NASDAQ:HWH	USA	$1.71 Million
Donegal Investment Group PLC IR:DQ7A	Ireland	€14.60 Million
Painchek Ltd AU:PCK	Australia	AU$9.06 Million
Knightscope Inc NASDAQ:KSCP	USA	$13.49 Million
Millennium Pharmacon International JK:SDPC	Indonesia	Rp1.60 Trillion
Airo Lam limited NSE:AIROLAM	India	Rs1.56 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Neuroscientific Biopharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See NSB equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	31.62	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	5.33	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.01	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.01	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Neuroscientific Biopharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Neuroscientific Biopharmaceuticals Ltd (2016–2025)

The table below shows the annual total liabilities of Neuroscientific Biopharmaceuticals Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$149.22K ≈ $105.59K	+74.16%
2024-06-30	AU$85.68K ≈ $60.63K	-85.66%
2023-06-30	AU$597.36K ≈ $422.67K	-73.06%
2022-06-30	AU$2.22 Million ≈ $1.57 Million	+892.65%
2021-06-30	AU$223.41K ≈ $158.08K	+152.35%
2020-06-30	AU$88.53K ≈ $62.64K	+41.70%
2019-06-30	AU$62.48K ≈ $44.21K	-18.21%
2018-06-30	AU$76.39K ≈ $54.05K	+77.02%
2017-06-30	AU$43.15K ≈ $30.53K	-64.66%
2016-06-30	AU$122.12K ≈ $86.41K	--

About Neuroscientific Biopharmaceuticals Ltd

AU:NSB Australia Biotechnology

Market Cap

$14.35 Million

AU$20.29 Million AUD

Market Cap Rank

#26192 Global

#1173 in Australia

Share Price

AU$0.06

Change (1 day)

+1.67%

52-Week Range

AU$0.06 - AU$0.17

All Time High

AU$0.52